Pharmaceutical formulation comprising esomeprazole and sodium bicarbonate
The present invention relates to a stable pharmaceutical formulation comprising omeprazole, its enantiomer, or its pharmaceutically acceptable salt, and sodium bicarbonate, and a method for preparing the same. Specifically, the present invention provides a stable formulation by preventing omeprazole, its enantiomer, or its pharmaceutically acceptable salt, from coming in direct contact with sodium bicarbonate, to reduce the production of impurities.
1. A pharmaceutical formulation comprising a first layer, a second layer, a third layer, and a fourth layer;
the first layer comprising omeprazole, its enantiomer, or its pharmaceutically acceptable salt;
the second layer comprising a coating agent, wherein the coating agent is polyvinyl alcohol;
the third layer comprising an antacid, wherein the antacid is sodium bicarbonate; and
the fourth layer comprising a coating agent, wherein the coating agent is polyvinyl alcohol;
wherein the second layer separates the first layer from the third layer.
2. The pharmaceutical formulation according to claim 1 , wherein the ratio of the coating agent in the second and fourth layers to the omeprazole, its enantiomer, or its pharmaceutically acceptable salt, is from 0.1:1 to 7:1 by weight.
3. The pharmaceutical formulation according to claim 2 , wherein the ratio of the coating agent in the second and fourth layers to the omeprazole, its enantiomer, or its pharmaceutically acceptable salt, is from 1.5:1 to 5:1 by weight.
4. The pharmaceutical formulation according to claim 1 , wherein the omeprazole, its enantiomer, or its pharmaceutically acceptable salt is esomeprazole.
5. The pharmaceutical formulation according to claim 1 , wherein the omeprazole, its enantiomer, or its pharmaceutically acceptable salt is a magnesium salt of esomeprazole.
6. A method for preparing a pharmaceutical formulation comprising omeprazole, its enantiomer, or its pharmaceutically acceptable salt; and sodium bicarbonate, the method comprising the steps:
coating a core with a coating solution comprising omeprazole, its enantiomer, or its pharmaceutically acceptable salt to prepare a first coated material;
coating the first coated material with a second coating solution comprising polyvinyl alcohol to prepare a second coated material;
tableting the second coated material with sodium bicarbonate to prepare a core tablet; and
coating the core tablet with a third coating solution comprising polyvinyl alcohol.
7. A method for preparing a pharmaceutical formulation comprising 20 mg or 40 mg of esomeprazole magnesium trihydrate based on the weight of esomeprazole, and 800 mg of sodium bicarbonate, the method comprising the steps:
coating a core with a coating solution comprising esomeprazole magnesium trihydrate to prepare a first coated material;
coating the first coated material with a second coating solution comprising polyvinyl alcohol to prepare a second coated material;
tableting the second coated material with sodium bicarbonate to prepare a core tablet; and
coating the core tablet with a third coating solution comprising polyvinyl alcohol.